See also
ˇ Show More
Abbott Laboratories, Common-Size Consolidated Statement of Financial Position, Liabilities and Stockholders' Equity
| Dec 31, 2011 | Dec 31, 2010 | Dec 31, 2009 | Dec 31, 2008 | Dec 31, 2007 | ||
|---|---|---|---|---|---|---|
![]() |
Short-term borrowings | 3.90 | 7.32 | 9.50 | 3.99 | 4.60 |
![]() |
Trade accounts payable | 2.86 | 2.58 | 2.44 | 3.19 | 3.07 |
![]() |
Salaries, wages and commissions | 2.09 | 2.23 | 2.13 | 2.38 | 2.16 |
![]() |
Accrued rebates payable to government agencies | 1.74 | 1.51 | 1.22 | 1.36 | 1.67 |
![]() |
Accrued other rebates | 2.05 | 1.45 | 1.27 | 1.07 | 1.12 |
![]() |
All other | 9.24 | 7.15 | 5.83 | 7.51 | 6.56 |
![]() |
Other accrued liabilities | 13.03% | 10.12% | 8.32% | 9.94% | 9.35% |
![]() |
Dividends payable | 1.25 | 1.14 | 1.18 | 1.32 | 1.27 |
![]() |
Income taxes payable | 0.85 | 2.20 | 0.84 | 1.90 | 0.20 |
![]() |
Obligation in connection with conclusion of the TAP Pharmaceutical Products Inc. joint venture | – | – | 0.07 | 2.16 | – |
![]() |
Current portion of long-term debt | 1.70 | 3.44 | 0.40 | 2.45 | 2.26 |
![]() |
Current liabilities | 25.68% | 29.03% | 24.90% | 27.33% | 22.92% |
![]() |
Long-term debt, excluding current portion | 19.97 | 21.06 | 21.49 | 20.54 | 23.89 |
![]() |
Defined benefit pension plans and post-employment medical and dental plans for significant plans | 5.48 | 4.08 | 4.57 | 6.40 | 4.72 |
![]() |
Deferred income taxes | 1.17 | – | – | – | – |
![]() |
All other | 7.01 | 8.03 | 5.36 | 4.44 | 3.59 |
![]() |
Post-employment obligations and other long-term liabilities | 13.65% | 12.11% | 9.92% | 10.83% | 8.31% |
![]() |
Noncurrent liabilities | 33.63% | 33.17% | 31.42% | 31.37% | 32.20% |
![]() |
Total liabilities | 59.31% | 62.20% | 56.31% | 58.70% | 55.12% |
![]() |
Preferred shares, one dollar par value, none issued | – | – | – | – | – |
![]() |
Common shares, without par value | 16.29 | 14.71 | 15.75 | 17.55 | 15.37 |
![]() |
Common shares held in treasury, at cost | -6.12 | -6.59 | -6.32 | -6.19 | -3.05 |
![]() |
Earnings employed in the business | 34.69 | 31.83 | 32.54 | 32.59 | 27.21 |
![]() |
Accumulated other comprehensive income (loss) | -4.31 | -2.30 | 1.63 | -2.74 | 5.24 |
![]() |
Abbott shareholders' investment | 40.55% | 37.65% | 43.60% | 41.21% | 44.77% |
![]() |
Noncontrolling interests in subsidiaries | 0.14 | 0.15 | 0.08 | 0.09 | 0.11 |
![]() |
Total shareholders' investment | 40.69% | 37.80% | 43.69% | 41.30% | 44.88% |
![]() |
Total liabilities and shareholders' investment | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
May 19, 2012